TRMT6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62825308791525E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62880819942757E-12 |
Normal-vs-Stage2 |
4.17554879561521E-13 |
Normal-vs-Stage3 |
9.99200722162641E-15 |
Normal-vs-Stage4 |
6.02962124673923E-13 |
Stage1-vs-Stage2 |
8.438400E-01 |
Stage1-vs-Stage3 |
7.895400E-01 |
Stage1-vs-Stage4 |
8.643400E-01 |
Stage2-vs-Stage3 |
7.550800E-01 |
Stage2-vs-Stage4 |
9.963600E-01 |
Stage3-vs-Stage4 |
7.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62891922173003E-12 |
Normal-vs-AfricanAmerican |
1.63624669369256E-12 |
Normal-vs-Asian |
2.15679999970853E-07 |
Caucasian-vs-AfricanAmerican |
6.621200E-01 |
Caucasian-vs-Asian |
3.766400E-01 |
AfricanAmerican-vs-Asian |
3.574200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.88737914186277E-15 |
Normal-vs-Female |
1.64668279012403E-12 |
Male-vs-Female |
2.408800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.34163857380099E-12 |
Normal-vs-Age(41-60Yrs) |
1.62625468647093E-12 |
Normal-vs-Age(61-80Yrs) |
1.64868119156836E-12 |
Normal-vs-Age(81-100Yrs) |
5.54659651541556E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.739000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.937400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.232600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.289800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.775400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.770600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.73720000004896E-07 |
Normal-vs-Grade 2 |
1.64257496493292E-12 |
Normal-vs-Grade 3 |
1.62525548574877E-12 |
Normal-vs-Grade 4 |
2.54762877460735E-12 |
Grade 1-vs-Grade 2 |
7.916400E-01 |
Grade 1-vs-Grade 3 |
7.718400E-01 |
Grade 1-vs-Grade 4 |
9.428600E-01 |
Grade 2-vs-Grade 3 |
1.120440E-01 |
Grade 2-vs-Grade 4 |
8.003800E-01 |
Grade 3-vs-Grade 4 |
5.352800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.36477504245158E-14 |
Normal-vs-ccB subtype |
1.64523950019202E-12 |
ccA subtype-vs-ccB subtype |
7.525800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.88578058618805E-15 |
Normal-vs-N1 |
1.772450E-04 |
N0-vs-N1 |
6.142200E-01 |
|
|